| Literature DB >> 30168024 |
Cecilia Higgs1, Yanick J Crow2, Denise M Adams3, Emmanuel Chang4,5, Don Hayes6,7, Utz Herbig8, James N Huang9, Ryan Himes10, Kunal Jajoo11, F Brad Johnson12, Susan D Reynolds6,13, Yoshihiro Yonekawa14,15, Mary Armanios16, Farid Boulad17, Courtney D DiNardo18, Carlo Dufour19, Frederick D Goldman20, Shakila Khan21, Christian Kratz22, Kasiani C Myers23, Ganesh Raghu24, Blanche P Alter1, Geraldine Aubert25,26, Sonia Bhala1, Edward W Cowen27, Yigal Dror28,29,30, Mounif El-Youssef31, Bruce Friedman32, Neelam Giri1, Lisa Helms Guba32, Payal P Khincha1, Tiffany F Lin9, Hilary Longhurst33, Lisa J McReynolds1, Adam Nelson23, Tim Olson34, Anne Pariser35, Rosario Perona36,37, Ghadir Sasa38, Kristen Schratz39, Douglas A Simonetto40, Danielle Townsley41, Michael Walsh17, Katherine Stevens32, Suneet Agarwal42, Alison A Bertuch43, Sharon A Savage44.
Abstract
Vascular complications such as bleeding due to gastrointestinal telangiectatic anomalies, pulmonary arteriovenous malformations, hepatopulmonary syndrome, and retinal vessel abnormalities are being reported in patients with telomere biology disorders (TBDs) more frequently than previously described. The international clinical care consortium of telomere-associated ailments and family support group Dyskeratosis Congenita Outreach, Inc. held a workshop on vascular abnormalities in the TBDs at the National Cancer Institute in October 2017. Clinicians and basic scientists reviewed current data on vascular complications, hypotheses for the underlying biology and developed new collaborations to address the etiology and clinical management of vascular complications in TBDs.Entities:
Keywords: Consortium; Dyskeratosis congenita; Telomere; Vascular biology
Mesh：
Year: 2018 PMID： 30168024 DOI： 10.1007/s10456-018-9640-7
Source DB: PubMed Journal: Angiogenesis ISSN： 0969-6970 Impact factor: 9.596